European Generic Medicines Association Calls For Changes In The Regulatory Framework For Generic Med

The European Generic Medicines Association (EGA)'s Vision 2015 calls for changes in the regulatory framework for generic and biosimilar medicines in order to create a globally competitive generic industry, increase patient access to affordable quality medicines and ensure sustainable healthcare in Europe. According to Greg Perry, director general of the EGA, 'Generic medicines are one of the most competitive sectors in Europe, accounting for almost 50% of all the medicines dispensed, bringing combined savings of between EUR25-30bn yearly. And yet numerous hurdles crop up as a result of anti-competitive activities that create unnecessary delays in the development and introduction

To read the full article, please choose one of the following options: